February issue reader poll
Gestational diabetes: Should you use oral agents?
Most relevant: 77%
Somewhat relevant: 3%
Least relevant: 20%
Examining the evidence on vitamin D, calcium, and CVD risk
Most relevant: 14%
Somewhat relevant: 75%
Least relevant: 11%
Oral contraceptives: What you need to know about the latest formulations
Most relevant: 55%
Somewhat relevant: 33%
Least relevant: 12%
Clinical Insights:
Infection resistance dips during ovulation
Most relevant: 11%
Somewhat relevant: 58%
Least relevant:31%
Twins from IVF help each other survive in utero
Most relevant: 31%
Somewhat relevant: 39%
Least relevant: 30%
US obesity rates: astronomical but leveling
Most relevant: 31%
Somewhat relevant: 39%
Least relevant: 30%
Moderately preterm infants have more emotional issues
Most relevant: 50%
Somewhat relevant: 47%
Least relevant: 3%
Smartphones may increase risk of health data breaches
Most relevant: 20%
Somewhat relevant: 69%
Least relevant: 11%
HHS overrules expanded availability of Plan B
Most relevant: 33%
Somewhat relevant: 47%
Least relevant: 20%
Legally Speaking: Lack of informed consent alleged after elective induction of labor
Most relevant: 67%
Somewhat relevant: 25%
Least relevant: 8%
SMFM Consult: Pregnancy in women with spinal cord injuries
Most relevant: 22%
Somewhat relevant: 55%
Least relevant: 23%
Meeting Coverage: ASRM takes on fertility knowledge gap, ‘personhood’ legislation
Most relevant: 19%
Somewhat relevant: 58%
Least relevant: 23%
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Study finds pregnancy risks higher with ART in kidney transplant recipients
July 11th 2025Women with kidney transplants who conceive through assisted reproductive technology face increased risks of complications such as hypertension, preterm birth, and cesarean delivery, according to new research.
Read More
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More